Pictor is revolutionizing the blood testing market. It has developed nanotechnology based patented products (combination of software, hardware and immunoassays) that provides accurate results, simplifies the operational process, and makes it affordable to do a panel of blood tests.
Location: Singapore
Employees: 11-50
Phone: +64 9-309 0950
Total raised: $11.1M
Founded date: 2006
Investors 3
Funding Rounds 2
| Date | Series | Amount | Investors |
| 05.12.2022 | - | $5M | - |
| 13.04.2022 | - | $6.1M | - |
Mentions in press and media 8
| Date | Title | Description |
| 22.05.2025 | Pictor Establishes U.S. Headquarters and Scales Operations, Revolutionizing Proteomics Testing Amid Regulatory Shift | CARLSBAD, Calif., May 22, 2025 /PRNewswire/ -- Pictor, a global leader in multiplex proteomics solutions, is excited to announce the establishment of its U.S. headquarters in Carlsbad, California, marking a significant milestone in its stra... |
| 05.12.2022 | Pictor Raises $5M in Funding Round | Pictor, an Auckland, New Zealand-based immunodiagnostics company, raised $5M in funding. The backers were not disclosed. The company intends to use the funds to accelerate pipeline product development projects along with market development ... |
| 01.08.2022 | Slone Partners Places Thomas Schlumpberger as Chief Executive Officer at Nanomix | “Thomas Schlumpberger is an experienced and admired leader in the POC diagnostics field where he has achieved extraordinary success in every management role,” said Slone Partners President Tara Kochis. SOUTH RIDING, Va. (PRWEB) August 01, 2... |
| 14.04.2022 | Health tech fund raises $800 million as COVID speeds up change in the medical industry | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign up to get it delivered free to your inbox. It was already well underway prior to COVID—the wave of innovation in health tech, that is. But n... |
| 13.04.2022 | Pictor raises $6.1M to bring its COVID-19 antibody test to market | The company has partnered with Mobility Health to launch the test in the US While some diseases are fairly easy to detect, others can be very difficult to diagnose; these are called complex diseases, and they are caused by the interaction o... |
| 20.01.2022 | Pictor Successfully Completes Validation Trial in U.S. for its SARS-Co-V-2 Antibody Test | SAN FRANCISCO (PRWEB) January 20, 2022 New Zealand diagnostic biotech company Pictor Ltd. announced today that it has successfully completed validation trials at two separate sites in the United States, one of which was Florida-based Boca B... |
| 17.11.2016 | Quarizon invests Rs1 crore in product photography start-up Pictor Imaging | Pictor claims to have completed pilots with the e-commerce companies in India. Quarizon invests Rs1 crore in product photography start-up Pictor Imaging 1 min read . Updated: 17 Nov 2016, 11:56 PM IST Arushi Chopra Pictor will use the funds... |
| - | Pictor | “PictorDx offers a flexible multiplex proteomics platform that delivers multiple biomarker insights simultaneously and cost-effectively for multiple sample types” |